Science Current Events | Science News | Brightsurf.com
 

Ovarian Tissue Current Events | Ovarian Tissue News

Sort By: Page Views | Date

Pregnancy is possible after cancer treatment
It has been reported for the first time in Germany that healthy ovarian tissue has been taken from a non-pregnant woman with cancer and then re-implanted after cancer therapy.   view more (2008-04-24)

Scientists report the first live births in large mammals after using frozen ovarian tissue
Lausanne, Switzerland: French scientists have succeeded in using previously frozen ovarian tissue to produce live offspring in large mammals for the first time. The team, led by Professor Bruno Salle and Dr Jacqueline Lornage of the Departement de Médecine de la Reproduction at the Hôpital Edouard Herriot in Lyon, reported that from... view more... (2001-07-01)

UK researchers raise hopes of preserving fertility for women with cancer
UK fertility experts have sounded a note of cautious optimism about the safety of preserving ovarian tissue and transplanting it back into women after cancer treatment. The optimism follows research reported today (Thursday 27 September) in Human Reproduction*, Europe's leading journal of reproductive medicine. It is the first reported non-test... view more... (2001-09-23)

Women without regular medical care at increased risk of ovarian cancer
In North America, ovarian cancer is the second most common gynecological cancer and is the leading cause of death among women with gynecological cancer. The high mortality is in part due to the difficulty of detecting and diagnosing this condition at an early stage.   view more (2007-03-27)

Cryopreservation techniques bring hopes for women cancer victims and endangered species
Emerging cryopreservation techniques are increasing hope of restoring fertility for women after diseases such as ovarian cancer that lead to destruction of reproductive tissue.   view more (2008-09-10)

Ovarian Cancer May Mimic Fallopian Tube Formation
A new study suggests that ovarian cancer cells form by hijacking a developmental genetic process normally used to form fallopian tubes. Scientists at the Georgia Institute of Technology and the Ovarian Cancer Institute discovered that the protein, PAX8, is involved in the development of fallopian tubes and is present in ovarian cancer cells, but... view more... (2007-03-07)

Study links obesity to elevated risk of ovarian cancer
A new epidemiological study has found that among women who have never used menopausal hormone therapy, obese women are at an increased risk of developing ovarian cancer compared with women of normal weight.   view more (2009-01-05)

New developments in biomarkers for epithelial ovarian cancer
With the genomic revolution radical improvement has been made in methods of detection of ovarian cancer.   view more (2007-11-30)

Detection of glycoprotein could identify ovarian and uterine cancers with poor prognosis (p 865)
Issue 13 September 2003 Embargoed 0001 h (London time) 12 September 2003. The detection of a specific protein molecule could help oncologists identify uterine and ovarian cancers with poor prognosis and thereby enable better disease management of women with aggressive uterine or ovarian cancer, suggest authors of a study in this week's issue of... view more... (2003-09-10)

Discovery of follicles offers hope of babies for Turner's syndrome girls
Lausanne, Switzerland: Swedish researchers have found that teenage girls with Turner's syndrome still have follicles in their ovaries which may be capable of producing eggs. This discovery offers hope that Turner's syndrome girls may be able to have babies in the future. Mr Julius Hreinsson, an embryologist in the Fertility Unit at Huddinge... view more... (2001-07-03)

PET-CT highly accurate for detecting ovarian cancer recurrence
The accuracy of PET-CT for detecting recurrent ovarian cancer is high, more accurate even than either CT or PET alone, says a new study by researchers from Massachusetts General Hospital in Boston.   view more (2006-05-02)

U of Minnesota study finds thalidomide shows promise for treatment of recurrent ovarian cancer
Thalidomide, a drug blamed in the 1950s for causing birth defects, is now showing promise as a safe and effective treatment for women with recurrent ovarian cancer, according to a study led by a University of Minnesota Cancer Center researcher.   view more (2008-02-28)

Increased ovarian cancer risk not found in women with breast cancer family history
Women with a strong family history of breast cancer but who don't have breast cancer genetic mutations can now be reassured that they are not at increased risk for ovarian cancer.   view more (2005-09-21)

Ultrasound could help couples undergoing IVF
Ultrasound-based tests allowing women undergoing in-vitro fertilization (IVF) to count their chickens before they've hatched may provide alternatives to the hormone-based tests used today. Less costly and invasive than the current ovarian reserve tests, clinicians may in future consider using ultrasound scans of a woman's ovaries to predict her... view more... (2007-03-15)

Cancer could return unless stored ovarian tissue undergoes adequate testing before re-implantation
Cancer patients who have been successfully treated for their disease face the prospect of its return if stored ovarian (or testicular) tissue is transplanted back into their bodies without adequate checks, according to researchers at two university hospitals in Israel.   view more (2008-04-22)

Early results indicate radiofreqency ablation useful in treating ovarian cancer metastasis
Percutaneous radiofrequency ablation, a procedure that uses a high frequency electric current to kill tumor cells, is effective in achieving local control in selected patients with metastasis from ovarian cancer.   view more (2006-09-29)

Drinking tea associated with lower risk of ovarian cancer
Women who drank at least two cups of tea a day had a lower risk of ovarian cancer than those who did not drink tea, according to a study in the December 12/26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.   view more (2005-12-13)

Glypican-3 gene function in regulating body size helps inform novel cancer treatments
In a leading study that has implications for the development of novel therapies for a number of breast, lung and ovarian cancers that have lost the expression of a gene called glypican-3 (GPC3), Sunnybrook researchers have discovered how the loss of the GPC3 gene induces overgrowth through certain growth factors such as Sonic Hedgehog which... view more... (2008-05-13)

Drug compound leads to death of ovarian cancer cells resistant to chemotherapy
In a discovery that may be useful for maintaining remission in chemo-resistant ovarian cancer, Yale scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the death of ovarian cancer cells by halting the activation of a protein pathway called mTOR.   view more (2008-04-18)

Study finds multiple markers for breast and ovarian cancer
Scientists from the Uppsala Branch of the Ludwig Institute for Cancer Research (LICR) have made a promising discovery that could improve the early diagnosis of breast and ovarian cancers through a simple blood test.   view more (2005-08-01)
Sort By: Page Views | Date
© 2009 BrightSurf.com